Technical Analysis for PYC - Physiomics Plc

Grade Last Price % Change Price Change
F 6.9 -1.43% -0.10
PYC closed down 1.43 percent on Friday, April 16, 2021, on 1.23 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical PYC trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Fell Below 200 DMA Bearish -1.43%
Upper Bollinger Band Walk Strength -1.43%
50 DMA Resistance Bearish -3.50%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.50%
200 DMA Support Bullish -3.50%
Upper Bollinger Band Touch Strength -3.50%
50 DMA Resistance Bearish -3.50%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.50%
Older End-of-Day Signals for PYC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace 1 day ago
Fell Below 10 DMA 1 day ago
10 DMA Resistance 1 day ago
Down 2% 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Physiomics Plc Description

Physiomics Plc is engaged in the provision of outsourced systems and computational biology services to pharmaceutical companies. The Company is focused on the development of Virtual Tumour Clinical, to directly predict optimal regimens for human clinical trials; Cardiac tox prediction service, to predict unwanted toxic side effects of drug candidates in the drug discovery process, and Drug combinations database, for researchers and clinicians to access literature data on pre-clinical and clinical regimens and their effects. Its services include Target Validation, Mechanism of Action Studies, Lead Selection, Clinical Pharmacokinetic/Pharmacodynamics (PK/PD), EASYAP/Cardiac Toxicity Service, Virtual Tumour Preclinical and Virtual Tumour Clinical. It offers a services and technology for predicting cardiac toxicity. It also focuses on offering offer Model Based Drug Development (MBDD) services, which include Population PKPD analysis of clinical data and Back-translational analysis.


Sector: Healthcare
Industry: Biotechnology
Keywords: Health Target Research Pharmaceutical Clinic Analysis Clinical Trial Biology Pharmaceutical Industry Drug Discovery Drug Development Omics Health Sciences Translation Validation Dynamics Pharmaceutical Companies Pharmaceutical Sciences Pre Clinical Development

Is PYC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 17.25
52 Week Low 2.31
Average Volume 549,254
200-Day Moving Average 7.07
50-Day Moving Average 7.22
20-Day Moving Average 6.73
10-Day Moving Average 6.91
Average True Range 0.41
ADX 24.89
+DI 23.56
-DI 11.50
Chandelier Exit (Long, 3 ATRs ) 6.27
Chandelier Exit (Short, 3 ATRs ) 7.37
Upper Bollinger Band 7.22
Lower Bollinger Band 6.24
Percent B (%b) 0.68
BandWidth 14.53
MACD Line -0.01
MACD Signal Line -0.09
MACD Histogram 0.0785
Fundamentals Value
Market Cap 6.72 Million
Num Shares 97.3 Million
EPS -0.10
Price-to-Earnings (P/E) Ratio -69.00
Price-to-Sales 5.40
Price-to-Book 4.33
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.20
Resistance 3 (R3) 7.20 7.10 7.15
Resistance 2 (R2) 7.10 7.02 7.10 7.13
Resistance 1 (R1) 7.00 6.98 7.05 7.00 7.12
Pivot Point 6.90 6.90 6.93 6.90 6.90
Support 1 (S1) 6.80 6.82 6.85 6.80 6.68
Support 2 (S2) 6.70 6.78 6.70 6.67
Support 3 (S3) 6.60 6.70 6.65
Support 4 (S4) 6.60